Sylvia Wilder

3.3k citations

21 papers · 2.7k indexed · 2 hit papers · h-index 15

Impact in

Oncology top 2%
- Cancer-related Molecular Pathways
Cancer Research top 5%

Papers in

Biotechnology 6
- Cancer Research and Treatments 5
Oncology 8
- Cancer-related Molecular Pathways 8

Co-authors: Moshe Oren Mia Horowitz David Israeli Orly Reiner Martina Müller Min Li‐Weber Scott L. Friedman Peter R. Galle
Journals: Molecular Cell (4 papers)Molecular and Cellular Biology (3 papers)Cancer Cell (2 papers)Cell Death and Differentiation (2 papers)Peptides (1 paper)
Partner nations: Israel United States Croatia

In The Last Decade

Sylvia Wilder

21 papers receiving 2.7k citations

Hit Papers

align trajectories log scale

Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer 2013 · 390 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Cancer Cell
1998 The Journal of Experimental Medicine

Peers

Countries citing papers authored by Sylvia Wilder

Since Specialization

Citations

This map shows the geographic impact of Sylvia Wilder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Wilder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Wilder more than expected).

Fields of papers citing papers by Sylvia Wilder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia Wilder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Wilder. The network helps show where Sylvia Wilder may publish in the future.

Co-authors

The 25 scholars most cited alongside Sylvia Wilder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sylvia Wilder Line = papers co-authored together Sylvia Wilder links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Guidelines for the Detection of NADPH Oxidases by Immunoblot and RT-qPCR Methods in molecular biology ·Becky A. Diebold, Sylvia Wilder, Xavier De Deken, Jennifer L. Meitzler, James H. Doroshow, James McCoy, Yerun Zhu, E. Appelt	2019	14
2	Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth Cell Death and Differentiation ·S Harel, Noa Bossel Ben‐Moshe, Yael Aylon, Débora Rosa Bublik, Neta Moskovits, 秋生中川, Pedro Henrique Soares Ramos, Wahiddin Sugeng Riyanto, Gilad Fuchs, Sylvia Wilder, Asaf Hellman, Giovanni Blandino, Eytan Domany, Moshe Oren	2015	61
3	RNF20 and USP44 Regulate Stem Cell Differentiation by Modulating H2B Monoubiquitylation Molecular Cell ·Gilad Fuchs, Efrat Shema, Donna Stringer-Moore, Eran Kotler, 刘希栋, Sylvia Wilder, Lior Golomb, Ariel Pribluda, Feng Zhang, Mahmood Haj‐Yahya, Ester Feldmesser, Ashraf Brik, Xiaochun Yu, Jacob H. Hanna, Daniel Aberdam, Eytan Domany, Moshe Oren	2015	1
4	Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer Cancer Cell ·Tomer Cooks, Ioannis S. Pateras, Ohad Tarcic, Hilla Solomon, Aaron J. Schetter, Sylvia Wilder, Guillermina Lozano, Eli Pikarsky, Tim Forshew, Chalida Leksoomboon, Noam Harpaz, Steven H. Itzkowitz, Curtis C. Harris, S. E. Ped’, Vassilis G. Gorgoulis, Moshe Oren Hit paper breakdown →	2013	390
5	Mutant p53 Prolongs NF-kB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer Cancer Cell ·Tomer Cooks, Ioannis S. Pateras, Ohad Tarcic, Hilla Solomon, Aaron J. Schetter, Sylvia Wilder, Guillermina Lozano, Eli Pikarsky, Tim Forshew, Nitzan Rosenfeld, Noam Harpaz, Steven H. Itzkowitz, Curtis C. Harris, Varda Rotter, Vassilis G. Gorgoulis, Moshe Oren	2013	6
6	RNF20 and USP44 Regulate Stem Cell Differentiation by Modulating H2B Monoubiquitylation Molecular Cell ·Gilad Fuchs, Efrat Shema, Donna Stringer-Moore, Eran Kotler, 刘希栋, Sylvia Wilder, Lior Golomb, Ariel Pribluda, Feng Zhang, Mahmood Haj‐Yahya, Ester Feldmesser, Ashraf Brik, Xiaochun Yu, Jacob H. Hanna, Daniel Aberdam, Eytan Domany, Moshe Oren	2012	173
7	Importin 7 and Exportin 1 Link c-Myc and p53 to Regulation of Ribosomal Biogenesis Molecular Cell ·Lior Golomb, Débora Rosa Bublik, Sylvia Wilder, Reinat Nevo, Vladimir Kiss, Kristina Grabušić, Siniša Volarević, Moshe Oren	2012	6
8	Importin 7 and Exportin 1 Link c-Myc and p53 to Regulation of Ribosomal Biogenesis Molecular Cell ·Lior Golomb, Débora Rosa Bublik, Sylvia Wilder, Reinat Nevo, Vladimir Kiss, Kristina Grabušić, Siniša Volarević, Moshe Oren	2012	100
9	The PI3K inhibitor LY294002 prevents p53 induction by DNA damage and attenuates chemotherapy-induced apoptosis Cell Death and Differentiation ·Jair Bar, MohamedH. Mohamed, Amir Zalcenstein, Sylvia Wilder, Rony Seger, Moshe Oren	2005	44
10	Characterization of two peptide epitopes on Mdm2 oncoprotein that affect p53 degradation Peptides ·Moshe Balass, Egan H., 杜德田, Sylvia Wilder, Moshe Oren, Ephraim Katchalski‐Katzir	2002	8
11	The c- fos Proto-Oncogene Is a Target for Transactivation by the p53 Tumor Suppressor Molecular and Cellular Biology ·Adi Elkeles, Tamar Juven‐Gershon, David Israeli, Sylvia Wilder, Amir Zalcenstein, Moshe Oren	1999	58
12	p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs The Journal of Experimental Medicine ·Martina Müller, Sylvia Wilder, Danika L. Bannasch, David Israeli, M. Hengel, Min Li‐Weber, Scott L. Friedman, Peter R. Galle, Wolfgang Stremmel, Moshe Oren, Peter H. Krammer Hit paper breakdown →	1998	704
13	p53-Mediated Cell Death: Relationship to Cell Cycle Control Molecular and Cellular Biology ·Elisheva Yonish-Rouach, Didier Grünwald, Sylvia Wilder, Adi Kimchi, Evelyne May, Jean‐Jacques Lawrence, Pierre May, Moshe Oren	1993	89
14	p53-mediated cell death: relationship to cell cycle control. Molecular and Cellular Biology ·Elisheva Yonish-Rouach, Didier Grünwald, Sylvia Wilder, Adi Kimchi, E May, J. J. Lawrence, Pierre May, Moshe Oren	1993	287
15	Three unique base pair changes in a family with Gaucher disease Human Genetics ·Nurit Eyal, Nurit Firon, Sylvia Wilder, I. D. Gridnev, Mia Horowitz	1991	46
16	Molecular Aspects of Gaucher Disease Developmental Neuroscience ·Muxammadiyeva S.B. Babadjanova Sh. A., Silvia Jurley Matajira Tarazona, Nurit Eyal, Sylvia Wilder, TASYA LESTARI, Edwin H. Kolodny, Ari Zimran, Mia Horowitz	1991	12
17	Prevalent and rare mutations among Gaucher patients Gene ·Nurit Eyal, Sylvia Wilder, Mia Horowitz	1990	101
18	The human glucocerebrosidase gene and pseudogene: Structure and evolution Genomics ·Mia Horowitz, Sylvia Wilder, Zeev Horowitz, Orly Reiner, Terri Gelbart, Ernest Beutler	1989	337
19	Characterization of mutations in Gaucher patients by cDNA cloning. PubMed ·Gvozdev O.G., Nurit Firon, Zebulun D. Horowitz, Sylvia Wilder, Shizi Wu, Orly Reiner, Mia Horowitz	1989	68
20	Efficient In Vitro and In Vivo Expression of Human Glucocerebrosidase cDNA DNA ·Orly Reiner, Sylvia Wilder, David Givol, Mia Horowitz	1987	29

About Sylvia Wilder

Sylvia Wilder is a scholar working on Biotechnology, Oncology, Molecular Biology, Physiology and Cancer Research, having authored 21 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Glycosylation and Glycoproteins Research (6 papers), Lysosomal Storage Disorders Research (6 papers), Cancer Research and Treatments (5 papers), Cell death mechanisms and regulation (3 papers), Ubiquitin and proteasome pathways (3 papers), Epigenetics and DNA Methylation (3 papers) and Nuclear Structure and Function (2 papers). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (464 citations), Cell Biology (492 citations), Molecular Biology (1.9k citations) and Biotechnology (233 citations). Sylvia Wilder has collaborated with scholars based in Israel, United States and Croatia. Frequent co-authors include Moshe Oren, Mia Horowitz, David Israeli, Orly Reiner, Martina Müller, Min Li‐Weber, Scott L. Friedman, Peter R. Galle, Peter H. Krammer and Wolfgang Stremmel. Their work appears in journals such as Molecular Cell, Molecular and Cellular Biology, Cancer Cell, Cell Death and Differentiation and Peptides.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact